A Ketogenic Diet Sensitizes Pancreatic Cancer to Inhibition of Glutamine Metabolism

Area of Science:

• Oncology
• Metabolic pathways
• Nutritional biochemistry

Background:

• Pancreatic cancer is a leading cause of cancer death with poor response to conventional chemotherapy.
• Alternative therapeutic strategies are needed, as ketogenic diets alone have limited efficacy.
• Glutamine metabolism modulators show preclinical promise but clinical impact is limited.

Purpose of the Study:

• To investigate the combined anti-tumor effects of a ketogenic diet and glutamine metabolism inhibitors in pancreatic cancer.
• To explore how a ketogenic diet alters tumor metabolism and creates therapeutic vulnerabilities.
• To provide a rationale for clinical studies combining ketogenic diets with targeted glutamine therapies.

Main Methods:

• Utilized murine pancreatic cancer models and in vitro metabolic simulations.
• Analyzed changes in TCA and glutamine-associated metabolites under ketogenic conditions.
• Assessed the anti-cancer effects of ketogenic diet combined with glutamine inhibitors (DON, CB839).

Main Results:

• Ketogenic diet increased TCA and glutamine metabolites in pancreatic cancer models.
• Metabolic shift induced by ketogenic diet increased reliance on glutamine anaplerosis.
• Combination of ketogenic diet with glutamine inhibitors demonstrated robust anti-cancer effects.

Conclusions:

• Ketogenic diet creates metabolic vulnerabilities in pancreatic cancer that can be targeted.
• Combining ketogenic diets with glutamine metabolism inhibitors offers a potent therapeutic strategy.
• Findings support further clinical investigation of this combined approach for pancreatic cancer treatment.